Health Catalyst(US:HCAT) Globenewswire·2025-02-26 21:03Core Insights - Health Catalyst, Inc. reported strong financial performance for the full year 2024, achieving total revenue of $307 million and Adjusted EBITDA of $26 million, with expectations for continued growth in 2025 [2][4][11] - The Technology segment generated $195 million in revenue for 2024, reflecting a 10% year-over-year growth, and is anticipated to grow faster than the overall business in 2025 [2][4] - The company has made leadership changes, including the appointment of Dr. Jill Hoggard Green to the Board of Directors and promotions within the leadership team [3] Financial Performance - For Q4 2024, total revenue was $79.6 million, a 6% increase from $75.1 million in Q4 2023 [4] - Gross profit for Q4 2024 was $28.6 million, up 20% from $23.9 million in Q4 2023, resulting in a gross margin of 36% [4] - The net loss for Q4 2024 was $20.7 million, a 32% improvement compared to a net loss of $30.3 million in Q4 2023 [4] Key Metrics - The number of Platform Clients increased to 130 in 2024, up from 109 in 2023 [5] - The Dollar-based Retention Rate for the Technology segment and Tech-Enabled Managed Services (TEMS) was 102% [7] - Cash and cash equivalents at the end of 2024 were $249.6 million, significantly higher than $106.3 million at the end of 2023 [17][24] Financial Outlook - For Q1 2025, the company expects total revenue of approximately $79 million and Adjusted EBITDA of approximately $4 million [11] - For the full year 2025, total revenue is projected to be approximately $335 million, with Technology revenue expected to reach approximately $220 million and Adjusted EBITDA targeted at approximately $41 million [11]